title: Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study.
abstract: OBJECTIVE
  Few data are available on the extent and prognostic value of reverse left ventricular remodelling (r-LVR) after ST-elevation acute myocardial infarction (STEMI). We sought to evaluate incidence, major determinants, and long-term clinical significance of r-LVR in a group of STEMI patients treated with primary percutaneous coronary intervention (PPCI). In particular, the role of preserved microvascular flow within the infarct zone in inducing r-LVR has been investigated.
  
  
  RESULTS
  Serial echocardiograms (2DE) and myocardial contrast study were obtained within 24 h of coronary recanalization (T1) and at pre-discharge (T2) in 110 reperfused STEMI patients. Follow-up 2DE was scheduled after 6 months (T3). Two-year clinical follow-up was obtained. Reverse remodelling was defined as a reduction >10% in LV end-systolic volume (LVESV) at 6 months follow-up. r-LVR occurred in 39% of study population. At multivariable analysis, independent predictors of r-LVR were an effective microvascular reflow within the infarct zone, the in-hospital improvement of myocardial perfusion, an initial large LVESV, and a short time to reperfusion. Cox analysis identified r-LVR as the only independent predictor of 2-year event-free survival. Combined events rate was significantly higher among patients without compared to those with r-LVR (log-rank test P < 0.05).
  
  
  CONCLUSIONS
  r-LVR frequently occurs in STEMI patients treated with PPCI and it is an important predictor of favourable long-term outcome. A preserved microvascular perfusion within the infarct zone is the major determinant of r-LVR.
authors.affiliation: Department of Cardiology, Catholic University of the Sacred Heart, Campobasso, Italy.
authors.forename: Stefania
authors.initials: S
authors.lastname: Funaro
authors.forename: Giuseppe
authors.initials: G
authors.lastname: La Torre
authors.forename: Mariapina
authors.initials: M
authors.lastname: Madonna
authors.forename: Leonarda
authors.initials: L
authors.lastname: Galiuto
authors.forename: Antonio
authors.initials: A
authors.lastname: Scarà
authors.forename: Alessandra
authors.initials: A
authors.lastname: Labbadia
authors.forename: Emanuele
authors.initials: E
authors.lastname: Canali
authors.forename: Antonella
authors.initials: A
authors.lastname: Mattatelli
authors.forename: Francesco
authors.initials: F
authors.lastname: Fedele
authors.forename: Francesco
authors.initials: F
authors.lastname: Alessandrini
authors.forename: Filippo
authors.initials: F
authors.lastname: Crea
authors.forename: Luciano
authors.initials: L
authors.lastname: Agati
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D003287:Contrast Media; D004452:Echocardiography / Q000379:methods; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D015588:Observer Variation; D010743:Phospholipids; D011379:Prognosis; D013459:Sulfur Hexafluoride; D020257:Ventricular Remodeling
chemical_list: D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D013459:Sulfur Hexafluoride